Syngene International Limited, commonly referred to as Syngene, is a leading global contract research and manufacturing organisation headquartered in Bengaluru, India. Founded in 1993, Syngene has established itself as a key player in the biopharmaceutical industry, providing integrated research and development services to clients across the globe. With a strong presence in North America, Europe, and Asia, Syngene offers a diverse range of services, including drug discovery, development, and manufacturing. The company is renowned for its innovative approach, leveraging cutting-edge technologies to deliver high-quality solutions tailored to client needs. Syngene's commitment to excellence has earned it a prominent market position, with notable achievements in collaborations with major pharmaceutical companies. Its unique blend of scientific expertise and operational efficiency sets Syngene apart in the competitive landscape of life sciences.
How does Syngene's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Syngene's score of 67 is higher than 82% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2024, Syngene International Limited reported total carbon emissions of approximately 61,010,000 kg CO2e for Scope 1, 13,012,000 kg CO2e for Scope 2, and 48,780,000 kg CO2e for Scope 3. This reflects a slight increase in Scope 1 emissions from 60,030,000 kg CO2e in 2023, while Scope 2 emissions decreased from 18,765,000 kg CO2e. Scope 3 emissions also saw a reduction from 89,418,000 kg CO2e in 2023. Syngene has set ambitious climate commitments, aiming to reduce its absolute Scope 1 and 2 greenhouse gas emissions by 54.6% by FY2033, using FY2023 as the baseline. Additionally, the company targets that 81.6% of its suppliers will have science-based targets by FY2028. For near-term goals, Syngene plans to reduce Scope 1 emissions by 30% and Scope 2 emissions by 25% from a 2021 baseline by 2030. The company’s emissions data is independently reported and does not cascade from any parent organization. Syngene is committed to aligning its targets with the Science Based Targets initiative (SBTi), ensuring that its reduction strategies are consistent with the global aim to limit warming to 1.5°C.
Access structured emissions data, company-specific emission factors, and source documents
| 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|
| Scope 1 | 3,440,000 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 2 | 11,263,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | 62,847,000 | 00,000,000 | 00,000,000 | 00,000,000 |
Syngene's Scope 3 emissions, which decreased by 45% last year and decreased by approximately 22% since 2021, demonstrating supply chain emissions tracking. Most of their carbon footprint comes from suppliers and value chain emissions, with Scope 3 emissions accounting for 72% of total emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 68% of Scope 3 emissions.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Syngene has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

Common questions about Syngene's sustainability data and climate commitments